pCA (vs. pLQ, RR and mixed)
| OR (95% CI) | p-value | |
|---|---|---|
| Sex (female vs. male) | 1.6 (0.4–6.7) | 0.54 |
| Age (>40 vs. ≤40 yrs) | 1.4 (0.7–2.8) | 0.32 |
| Disease Duration | 1.0 (0.9–1.1) | 0.17 |
| African American (vs. other) | 2.6 (1.3–5.3) | 0.007 |
| Years of education (>12 vs. ≤ yrs) | 0.7 (0.3–1.4) | 0.27 |
| Income | ||
| <30000$ | Ref | |
| 30000–65000$ | 0.4 (0.2–1.0) | 0.06 |
| ≥65000$ | 0.5 (0.2–1.2) | 0.12 |
| Smoking baseline (yes vs. no) | 2.1 (1.0–4.6) | 0.06 |
| SLEDAI baseline | 1.1 (1.0–1.2) | 0.002 |
| PGA baseline | 1.5 (1.0–2.2) | 0.04 |
| Cytotoxic therapy (≥75% vs. <75% of visits) | 1.1 (0.5–2.3) | 0.85 |
| Antimalaria therapy (≥75% vs. <75% of visits) | 0.5 (0.3–1.0) | 0.06 |
| Prednisolone therapy (≥75% vs. <75% of visits) | 1.1 (0.6–2.2) | 0.82 |